mali quote - 17nov

IM missing somthing here since when did bgp sell the marketing rights to skp,
please do a little more research and come back with facts(skp own the drug).
only the rights to market in america have been sold to Quintilles and bgp will still receive a revenue stream from this and be apart of the manufacturing of it.
and if you think one drug keeps a company the size of bgp afloat your wrong they have a good portfolio of drugs solereaze being the most marketable and they still have the rights for it in europe where it is doing well,it is pointless me listing all the drugs and services they provide but if you delve a little deeper you will see for yourself.